1971 related articles for article (PubMed ID: 15665227)
1. Three-dimensional dynamic susceptibility-weighted perfusion MR imaging at 3.0 T: feasibility and contrast agent dose.
Manka C; Träber F; Gieseke J; Schild HH; Kuhl CK
Radiology; 2005 Mar; 234(3):869-77. PubMed ID: 15665227
[TBL] [Abstract][Full Text] [Related]
2. Brain tumors: full- and half-dose contrast-enhanced MR imaging at 3.0 T compared with 1.5 T--Initial Experience.
Krautmacher C; Willinek WA; Tschampa HJ; Born M; Träber F; Gieseke J; Textor HJ; Schild HH; Kuhl CK
Radiology; 2005 Dec; 237(3):1014-9. PubMed ID: 16237142
[TBL] [Abstract][Full Text] [Related]
3. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
Warmuth C; Gunther M; Zimmer C
Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
[TBL] [Abstract][Full Text] [Related]
4. Glial neoplasms: dynamic contrast-enhanced T2*-weighted MR imaging.
Knopp EA; Cha S; Johnson G; Mazumdar A; Golfinos JG; Zagzag D; Miller DC; Kelly PJ; Kricheff II
Radiology; 1999 Jun; 211(3):791-8. PubMed ID: 10352608
[TBL] [Abstract][Full Text] [Related]
5. Comparison of contrast agents with high molarity and with weak protein binding in cerebral perfusion imaging at 3 T.
Thilmann O; Larsson EM; Björkman-Burtscher IM; Ståhlberg F; Wirestam R
J Magn Reson Imaging; 2005 Nov; 22(5):597-604. PubMed ID: 16200539
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced, high-resolution, susceptibility-weighted magnetic resonance imaging of the brain: dose-dependent optimization at 3 tesla and 1.5 tesla in healthy volunteers.
Noebauer-Huhmann IM; Pinker K; Barth M; Mlynarik V; Ba-Ssalamah A; Saringer WF; Weber M; Benesch T; Witoszynskyj S; Rauscher A; Reichenbach JR; Trattnig S
Invest Radiol; 2006 Mar; 41(3):249-55. PubMed ID: 16481907
[TBL] [Abstract][Full Text] [Related]
7. Focal liver lesions: SPIO-, gadolinium-, and ferucarbotran-enhanced dynamic T1-weighted and delayed T2-weighted MR imaging in rabbits.
Schnorr J; Wagner S; Abramjuk C; Drees R; Schink T; Schellenberger EA; Pilgrimm H; Hamm B; Taupitz M
Radiology; 2006 Jul; 240(1):90-100. PubMed ID: 16684917
[TBL] [Abstract][Full Text] [Related]
8. Uterine tumors: comparison of 3D versus 2D T2-weighted turbo spin-echo MR imaging at 3.0 T--initial experience.
Hori M; Kim T; Onishi H; Ueguchi T; Tatsumi M; Nakamoto A; Tsuboyama T; Tomoda K; Tomiyama N
Radiology; 2011 Jan; 258(1):154-63. PubMed ID: 21045182
[TBL] [Abstract][Full Text] [Related]
9. Solid pancreatic lesions: characterization by using timing bolus dynamic contrast-enhanced MR imaging assessment--a preliminary study.
Kim JH; Lee JM; Park JH; Kim SC; Joo I; Han JK; Choi BI
Radiology; 2013 Jan; 266(1):185-96. PubMed ID: 23192779
[TBL] [Abstract][Full Text] [Related]
10. Assessment of cerebral perfusion by first-pass, dynamic, contrast-enhanced, steady-state free-precession MR imaging: an animal study.
Runge VM; Kirsch JE; Wells JW; Woolfolk CE
AJR Am J Roentgenol; 1993 Mar; 160(3):593-600. PubMed ID: 8430562
[TBL] [Abstract][Full Text] [Related]
11. [Studies on contrast medium dosage in perfusion-weighted MR imaging].
Erb G; Benner T; Heiland S; Reith W; Sartor K; Forsting M
Rofo; 1997 Dec; 167(6):599-604. PubMed ID: 9465955
[TBL] [Abstract][Full Text] [Related]
12. Intraindividual comparison of gadobenate dimeglumine and gadobutrol for cerebral magnetic resonance perfusion imaging at 1.5 T.
Essig M; Lodemann KP; Le-Huu M; Brüning R; Kirchin M; Reith W
Invest Radiol; 2006 Mar; 41(3):256-63. PubMed ID: 16481908
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of optimized gadolinium-enhanced fast fluid-attenuated inversion recovery MR imaging in revealing lesions of the brain.
Melhem ER; Bert RJ; Walker RE
AJR Am J Roentgenol; 1998 Sep; 171(3):803-7. PubMed ID: 9725320
[TBL] [Abstract][Full Text] [Related]
14. Intraindividual comparison between gadopentetate dimeglumine and gadobutrol for magnetic resonance perfusion in normal brain and intracranial tumors at 3 Tesla.
Giesel FL; Mehndiratta A; Risse F; Rius M; Zechmann CM; von Tengg-Kobligk H; Gerigk L; Kauczor HU; Politi M; Essig M; Griffiths PD; Wilkinson ID
Acta Radiol; 2009 Jun; 50(5):521-30. PubMed ID: 19337867
[TBL] [Abstract][Full Text] [Related]
15. Sensitivity encoding for diffusion-weighted MR imaging at 3.0 T: intraindividual comparative study.
Kuhl CK; Gieseke J; von Falkenhausen M; Textor J; Gernert S; Sonntag C; Schild HH
Radiology; 2005 Feb; 234(2):517-26. PubMed ID: 15671005
[TBL] [Abstract][Full Text] [Related]
16. Breast lesions: evaluation with dynamic contrast-enhanced T1-weighted MR imaging and with T2*-weighted first-pass perfusion MR imaging.
Kvistad KA; Rydland J; Vainio J; Smethurst HB; Lundgren S; Fjøsne HE; Haraldseth O
Radiology; 2000 Aug; 216(2):545-53. PubMed ID: 10924584
[TBL] [Abstract][Full Text] [Related]
17. Echoplanar MR imaging for ultrafast detection of brain lesions.
Patel MR; Siewert B; Klufas R; Yousuf N; Edelman RR; Warach S
AJR Am J Roentgenol; 1999 Aug; 173(2):479-85. PubMed ID: 10430158
[TBL] [Abstract][Full Text] [Related]
18. Gadobenate dimeglumine-enhanced MR imaging breast vascular maps: association between invasive cancer and ipsilateral increased vascularity.
Sardanelli F; Iozzelli A; Fausto A; Carriero A; Kirchin MA
Radiology; 2005 Jun; 235(3):791-7. PubMed ID: 15845796
[TBL] [Abstract][Full Text] [Related]
19. Phase-sensitive inversion-recovery MR imaging in the detection of myocardial infarction.
Huber AM; Schoenberg SO; Hayes C; Spannagl B; Engelmann MG; Franz WM; Reiser MF
Radiology; 2005 Dec; 237(3):854-60. PubMed ID: 16304107
[TBL] [Abstract][Full Text] [Related]
20. Gadolinium-enhanced echo-planar T2-weighted MRI of tumors in the extracranial head and neck: feasibility study and preliminary results using a distributed-parameter tracer kinetic analysis.
Bisdas S; Baghi M; Wagenblast J; Vogl TJ; Thng CH; Koh TS
J Magn Reson Imaging; 2008 May; 27(5):963-9. PubMed ID: 18407543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
